Wang et al. reported that TRIM33 antagonization of PU.1 at the -117.3 kb Bcl2l11 enhancer is required for B-ALL cell survival [40]. The gene discussed is BCL2L11; the disease is precursor B-cell acute lymphoblastic leukemia.